Factor This Power Engineering
Live Events
DTECH⢠Events
POWERGEN®
Calendar
Resource Center
Webinars
Podcasts
White Papers
Contribute Content
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Project Development
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Resource Center
Webinars
Podcasts
Whitepapers
Calendar
Contribute Content
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
66.06
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DexCom, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
38
39
Next >
Discover which S&P500 stocks are making waves on Friday.
February 14, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via
Chartmill
DexCom Analysts Increase Their Forecasts After Q4 Earnings
February 14, 2025
Via
Benzinga
Dexcom Q4 Earnings: Expanding Sales, New Products, Margin Pressure And More
February 14, 2025
Dexcom reported Q4 results, with revenue up 8%, beating estimates. CEO looks forward to unlocking next wave of global access.
Via
Benzinga
DexCom (DXCM) Q4 2024 Earnings Call Transcript
February 13, 2025
DXCM earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
DexCom: Revenue Up, EPS Misses Mark
February 13, 2025
DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short.
Via
The Motley Fool
Earnings Scheduled For February 13, 2025
February 13, 2025
Via
Benzinga
Should You Buy DexCom Stock Before Feb. 13?
February 06, 2025
Via
The Motley Fool
Deep Dive Into DexCom Stock: Analyst Perspectives (5 Ratings)
February 03, 2025
Via
Benzinga
Expert Outlook: DexCom Through The Eyes Of 11 Analysts
January 16, 2025
Via
Benzinga
DexCom’s (NASDAQ:DXCM) Q4: Beats On Revenue
February 13, 2025
Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 7.6% year on year to $1.11 billion. The company expects the full year’s...
Via
StockStory
Topics
Artificial Intelligence
Dexcom Tumbles As Fourth-Quarter Profit Lags Expectations
February 13, 2025
Dexcom stock fell late Thursday after the company missed fourth-quarter profit expectations by a nickel per share.
Via
Investor's Business Daily
Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results
February 13, 2025
From
DexCom, Inc.
Via
Business Wire
DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect
February 12, 2025
Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings tomorrow after the bell. Here’s what investors should know.
Via
StockStory
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
February 10, 2025
Based on a technical and fundamental analysis of NASDAQ:DXCM we can say: DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Via
Chartmill
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
January 16, 2025
Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.
Via
Chartmill
NASDAQ:DXCM qualifies as a high growth stock and is consolidating.
December 25, 2024
DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.
Via
Chartmill
1 Reason to Sell DexCom Stock, and 1 Reason to Buy
December 21, 2024
Via
The Motley Fool
Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade
February 03, 2025
Via
The Motley Fool
Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years
February 03, 2025
Via
The Motley Fool
For those who appreciate growth without the sticker shock, NASDAQ:DXCM is worth considering.
January 31, 2025
NASDAQ:DXCM is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced.
Via
Chartmill
Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.
January 30, 2025
From
DexCom, Inc.
Via
Business Wire
Lululemon To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Thursday
January 16, 2025
Via
Benzinga
This Netflix Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
January 16, 2025
Via
Benzinga
2 Healthcare Stocks to Buy Hand Over Fist in January
January 16, 2025
Via
The Motley Fool
Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook
January 13, 2025
From
DexCom, Inc.
Via
Business Wire
Health Tracking Is Moving To Smart Rings From Watches. Oura Leads Market.
January 09, 2025
Smart rings are one of the hottest consumer electronics categories, as evidenced by exhibitors at CES 2025. Oura leads the market.
Via
Investor's Business Daily
3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025
January 08, 2025
Via
The Motley Fool
Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025
From
DexCom, Inc.
Via
Business Wire
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024
January 04, 2025
Via
The Motley Fool
DEXCOM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DexCom, Inc. - DXCM
December 21, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
38
39
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.